A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients, Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
Pialoux G, Raffi F, Brun-Vezinet F, Meiffrédy V, Flandre P, Gastaut JA, Dellamonica P, Yeni P, Delfraissy JF, Aboulker JP. N Engl J Med, 1998 Oct 29;339(18):1269-76. doi: 10,1056/NEJM199810293391802.